CASP3 and colorectal carcinoma: The mechanism underlying these effects was further investigated, and the findings indicated that GA can inhibit CRC cells in vitro and in vivo by triggering caspase-3/GSDME-dependent pyroptosis, which further triggers an antitumor immune response that inhibits tumor growth.